A change to a single gene in the bacterium Yersinia pestis has enabled one of the world’s most notorious pathogens to survive ...

Tariffs could be a hidden opportunity for packaging professionals to re-evaluate and diversify suppliers.

After years of little innovation, a number of new treatments are entering Phase II and III schizophrenia clinical research. As the demand for trial sites increases, this means that less experienced ...

AI will deliver transformative therapies at an exponential scale, addressing the complexities of biology that traditional ...

Psychedelics are moving from the counterculture to the mainstream. From Prince Harry's use of psilocybin to National Football ...

The global contract research organization (CRO) services market is expected to witness a growth rate of 9% in the next five ...

The Malvern location of Fujirebio Diagnostics Inc.’s played key role in the clinical development of the first FDA-approved ...

Wilson's new company, Philadelphia-based Gemma Biotherapeutics, plans to start testing gene therapies in Brazil this year.

Nestlé's Nescafé plans to invest an additional R$ 500 million in Brazil by 2028, the coffee brand said in a presentation to ...

The CBI has filed a chargesheet against former Jammu and Kashmir governor Satyapal Malik and seven others in connection with ...

Wasatch International Select Fund - Investor Class finished up 4.10% but underperformed the benchmark MSCI EAFE Index, which ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said ...